ClariVest Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $2.17M | Hold |
4,632
| – | – | 0.22% | 126 |
|
|
2024
Q2 | $2.17M | Sell |
4,632
-40
| -0.9% | -$18.7K | 0.22% | 126 |
|
|
2024
Q1 | $1.95M | Sell |
4,672
-10,900
| -70% | -$4.56M | 0.2% | 141 |
|
|
2023
Q4 | $6.34M | Sell |
15,572
-3,073
| -16% | -$1.25M | 0.35% | 58 |
|
|
2023
Q3 | $6.48M | Sell |
18,645
-1,206
| -6% | -$419K | 0.35% | 61 |
|
|
2023
Q2 | $6.99M | Sell |
19,851
-3,500
| -15% | -$1.23M | 0.35% | 64 |
|
|
2023
Q1 | $7.36M | Sell |
23,351
-700
| -3% | -$221K | 0.33% | 67 |
|
|
2022
Q4 | $6.95M | Buy |
+24,051
| New | +$6.95M | 0.33% | 73 |
|
|
2021
Q3 | – | Sell |
-2,300
| Closed | -$464K | – | 833 |
|
|
2021
Q2 | $464K | Sell |
2,300
-54,872
| -96% | -$11.1M | 0.02% | 436 |
|
|
2021
Q1 | $12.3M | Sell |
57,172
-6,100
| -10% | -$1.31M | 0.43% | 54 |
|
|
2020
Q4 | $15M | Sell |
63,272
-10,163
| -14% | -$2.4M | 0.51% | 46 |
|
|
2020
Q3 | $20M | Buy |
73,435
+27,173
| +59% | +$7.39M | 0.65% | 33 |
|
|
2020
Q2 | $13.4M | Buy |
46,262
+43,035
| +1,334% | +$12.5M | 0.37% | 62 |
|
|
2020
Q1 | $767K | Sell |
3,227
-200
| -6% | -$47.5K | 0.02% | 338 |
|
|
2019
Q4 | $750K | Buy |
+3,427
| New | +$750K | 0.02% | 386 |
|
|
2013
Q4 | – | Sell |
-69,739
| Closed | -$5.29M | – | 657 |
|
|
2013
Q3 | $5.29M | Buy |
69,739
+12
| +0% | +$910 | 0.24% | 99 |
|
|
2013
Q2 | $5.57M | Buy |
+69,727
| New | +$5.57M | 0.25% | 107 |
|